Telomir Pharmaceuticals Announces New Findings in a Prostate Cancer Model Demonstrating Telomir-1 Also Resets DNA Methylation of Tumor Suppressor Gene…

Findings show that Telomir-1 restores the body’s natural tumor suppressor defenses by reversing abnormal DNA methylation of ...
Labiotech.eu

AKIGAI takes EGFR inhibitors beyond cancer to treat neuropathic pain

Discover how AKIGAI’s EGFR inhibitors may redefine neuropathic pain therapy and offer hope for complex regional pain syndrome ...
Healio

Proton, photon radiation for breast cancer confer comparable health-related quality of life

Photon- and proton-based radiation therapy conferred comparable health-related quality of life for people with breast cancer, ...
Raw Story

'I feel guilty': Former anti-vaxxers horrified by RFK Jr disaster

When Heather Simpson decided she wanted to become a mother, she began researching healthy lifestyle choices to increase her ...
Science X Network

10 years, 10,000 lives: Mayo experts highlight the journey and future of proton beam and particle therapy at Mayo Clinic

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...
KIMT

Mayo Clinic sees proton therapy milestone with 10,000 patients

ROCHESTER, Minn. — The Mayo Clinic Proton Therapy Program in Rochester has reached a significant milestone by treating 10,000 patients a decade after its inception. The program says it now treats 30% ...
Game Rant

Borderlands 4: Where to Find Ordenite and Eridium in Electroshock Therapy

Marc Santos is a Guides Staff Writer from the Philippines. He's a seasoned writer with over four years of industry experience, and he is an enjoyer of all things difficult in gaming. If Marc's not ...
Morningstar

Ionis receives U.S. FDA Breakthrough Therapy designation for ION582 in Angelman syndrome

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ION582 for the treatment of Angelman ...
Detroit Free Press

Telomir Pharmaceuticals Reports In Vitro Data Supporting the Potential of Telomir-1 as a First-in-Class Epigenetic Therapy Influencing DNA Methylation Pathways in Cancer, Aging ...

In vitro findings reveal Telomir-1’s dual action: targeting DNA methylation switches and cutting into the Wnt “fuel line” that drives cancer growth. MIAMI, FLORIDA / ACCESS Newswire / August 28, 2025 ...